Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic
J Am Acad Dermatol
.
2020 Jun;82(6):e203-e204.
doi: 10.1016/j.jaad.2020.03.056.
Epub 2020 Mar 31.
Authors
Payal Shah
1
,
John G Zampella
2
Affiliations
1
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York.
2
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York. Electronic address: john.zampella@nyulangone.org.
PMID:
32244021
PMCID:
PMC7160444
DOI:
10.1016/j.jaad.2020.03.056
No abstract available
Publication types
Letter
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Immunomodulation*
Pandemics
Pneumonia, Viral
SARS-CoV-2